Belarus's republican centre for children with cancer and blood disorders, in Minsk. It hosts the national resource centre for children's palliative care, and its genetic biotechnology laboratory took part in the trial of a CAR T-cell product made in Belarus.
The European Observatory's 2013 review names the Republican Scientific Practical Centre for Paediatric Oncology, Haematology and Immunology as home to the Republican Resource Centre for the Palliative Care of Children. The phase 1 trial of the CD19 CAR T-cell product BY19, published in 2025, lists the centre's Laboratory of Genetic Biotechnologies, Minsk (postal code 223053), among its authors; the trial was run at two Belarusian centres and treated 23 children and adults with relapsed or refractory B-cell cancers, 17 of them with B-cell acute lymphoblastic leukaemia. The coordinates are an approximate Minsk point, not the building.
From OpenAlex, oncology works in the last five years (2022 to 2026, current year in progress); counted on 2026-11-19.
Matched to Belarusian Research Center For Pediatric Oncology and Hematology, including child institutions. 21 works · 72 citations · 95% open access · 24% clinical trials · 10% reviews.
Shares N.N. Alexandrov National Cancer Centre of Belarus, CAR-T cell therapy.
Shares N.N. Alexandrov National Cancer Centre of Belarus, Acute lymphoblastic leukaemia.
Shares Ministry of Health of the Republic of Belarus, N.N. Alexandrov National Cancer Centre of Belarus.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/